Anlotinib combined with pembrolizumab as first-line treatment for advanced pulmonary sarcomatoid carcinoma: a case report and literature review

Pulmonary sarcomatoid carcinoma (PSC) is an uncommon variant of non-small cell lung cancer (NSCLC), known for its unfavorable prognosis. Previous studies have elucidated that PSC generally exhibits a significant expression of programmed death-ligand 1 (PD-L1), an elevated tumor mutation burden, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Yingmei, Dong, Yi, Yi, Lina, Yang, Guifang, Xiao, Mengxia, Li, Qingqing, Zhao, Chen, Ye, Dafu, Yao, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618617/
https://www.ncbi.nlm.nih.gov/pubmed/37920159
http://dx.doi.org/10.3389/fonc.2023.1241475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618617/
https://www.ncbi.nlm.nih.gov/pubmed/37920159
http://dx.doi.org/10.3389/fonc.2023.1241475

Ejemplares similares